Amgen Inc (AMGN) stock

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3022% above fair value

$465.67−1.39 (-0.30%)

Close on Nov 13, 2026Market cap $251.76BP/E 27.0Yield 2.07%

Amgen statistics

111 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 2, 2027 (estimated, during market hours)
Last ex-dividend date: Nov 20, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $251.76B; $272.32M
Enterprise Value: $292.57B; $146.23M
PE Ratio: 27.00; 25.11
PS Ratio: 6.47; 3.66
PB Ratio: 17.54; 2.00
P/FCF Ratio: 26.28; 17.86
P/OCF Ratio: 20.92; 12.99

Enterprise valuationIndustry

EV / Sales: 7.52; 2.57
EV / EBITDA: 19.11; 16.50
EV / EBIT: 23.20; 19.31
EV / FCF: 30.54; 22.27

Share statisticsIndustry

Shares Outstanding: 541M; 58M
Shares Change (YoY): 0.51%; 10.8%
Shares Change (QoQ): 0.06%; 0.50%
Float: 540M; 49M
Shares Held by Insiders: 0.21%; 11.7%
Shares Held by Institutions: 82.7%; 56.4%

Short sellingIndustry

Short Interest: 13M; –
Short Interest Change: -5.87%; -0.80%
Short % of Float: 2.33%; 9.01%
Short % of Shares Outstanding: 2.33%; 6.30%
Days to Cover: 4.97; 5.15

Stock price statisticsIndustry

52-Week High: $483.99; –
52-Week Low: $312.38; –
20-Day Moving Average: $455.86; –
50-Day Moving Average: $425.31; –
200-Day Moving Average: $381.01; –
Average True Range (14): $11.47; –
Price Change (1 Week): 1.14%; -1.15%
Price Change (1 Month): 7.29%; -4.87%
Price Change (3 Months): 11.0%; -21.0%
Price Change (6 Months): 42.7%; -20.6%
Price Change (YTD): 42.3%; -23.6%
Price Change (1 Year): 38.5%; -22.4%
Price Change (3 Years): 72.5%; -29.5%
Price Change (5 Years): 120.3%; -77.9%
Price Change (10 Years): 218.0%; -65.4%
Average Volume (10 Days): 3M; –
Average Volume (20 Days): 3M; –
Average Volume (90 Days): 3M; –
Relative Volume: 0.78; 0.70
Relative Strength Index (14): 61.8; 43.4
Volatility (1 Year): 28.7%; 80.1%
Beta (5 Years): 0.41; 1.07

MarginsIndustry

Gross Margin: 70.9%; 53.1%
Operating Margin: 32.4%; -38.7%
Pretax Margin: 28.4%; -11.6%
Profit Margin: 24.1%; -31.6%
EBITDA Margin: 39.4%; -27.7%
FCF Margin: 24.6%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): 78.4%; -49.9%
Return on Assets (ROA): 10.1%; -40.6%
Return on Invested Capital (ROIC): 19.5%; -32.9%
Return on Capital Employed (ROCE): 17.3%; -37.9%

Financial positionIndustry

Current Ratio: 1.48; 3.30
Quick Ratio: 1.01; 2.39
Debt / Equity: 3.76; 0.49
Debt / EBITDA: 3.53; 3.15
Debt / FCF: 5.64; 4.65
Net Debt / EBITDA: 2.67; 1.97
Interest Coverage: 4.78; -6.35

GrowthIndustry

Revenue Growth (YoY): 8.15%; 6.82%
Net Income Growth (YoY): 34.1%; -14.4%
EPS Growth (YoY): 33.3%; -12.3%
FCF Growth (YoY): -17.0%; 6.85%
Revenue Growth (3Y CAGR): 11.8%; 2.25%
Revenue Growth (5Y CAGR): 7.65%; 6.41%
EPS Growth (3Y CAGR): 5.52%; 1.30%
EPS Growth (5Y CAGR): 2.94%; 3.78%

EfficiencyIndustry

Asset Turnover: 0.42; 0.40
Inventory Turnover: 1.78; 2.73
Revenue Per Employee: $1.24M; $429.29K
Profits Per Employee: $298.13K; -$689.41K
Employee Count: 31,500; 74
WACC: 7.02%; 10.2%

Income statement (TTM)Industry

Revenue: $38.90B; $66.37M
Gross Profit: $27.58B; $120.78M
Operating Income: $12.61B; -$21.37M
Pretax Income: $11.05B; -$12.95M
Net Income: $9.39B; -$22.35M
EBITDA: $15.31B; -$17.21M
EPS (Diluted): $17.25; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $13.19B; $68.68M
Total Debt: $54.01B; $116.91M
Net Cash (Debt): -$40.82B; $17.76M
Net Cash Per Share: -$75.50; $0.80
Equity (Book Value): $14.35B; $53.89M
Book Value Per Share: $26.55; $1.50
Tangible Book Value: -$23.85B; $27.13M
Working Capital: $11.13B; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $12.04B; -$12.38M
Capital Expenditures: -$2.45B; -$1.00M
Free Cash Flow: $9.58B; -$18.21M
FCF Per Share: $17.72; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 3.73%; -21.8%
FCF Yield: 3.81%; -9.44%
Dividend Yield: 2.07%; 1.88%
Shareholder Yield: 2.07%; 0.00%
Dividend Per Share: $9.66; $0.83
Dividend Growth (YoY): 5.81%; 2.37%
Years of Dividend Growth: 9; 0
Payout Ratio: 57.1%; 55.4%
FCF Payout Ratio: 56.0%; 43.7%

Taxes and interestIndustry

Interest Expense: $2.64B; $2.90M
Income Tax: $1.66B; $73.00K
Effective Tax Rate: 15.0%; 20.9%

Scores and fair valueIndustry

Graham Number: $101.51; $19.34
Graham Upside: -78.2%; -46.6%
Altman Z-Score: 2.54; 0.23
Piotroski F-Score: 7; 4
Beneish M-Score: -2.26; -2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	AMGN	S&P 500	Difference	AMGN per year	S&P 500 per year
1 month	+12.8%	-3.0%	+15.8 pts
3 months	+12.1%	-2.8%	+14.9 pts
Year to date	+45.2%	+11.5%	+33.7 pts
1 year	+42.4%	+13.5%	+29.0 pts
3 years	+91.0%	+77.7%	+13.3 pts	+24.1%	+21.1%
5 years	+157.4%	+72.6%	+84.8 pts	+20.8%	+11.5%
10 years	+321.0%	+308.2%	+12.8 pts	+15.5%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

13M AMGN shares were sold short on Oct 30, 2026, down 5.9% from the previous report, or 2.33% of the shares available to trade. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 55.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	12,592,756	-5.9%	2,534,680	5.0
Oct 15, 2026	13,378,638	-4.6%	2,691,096	5.0
Sep 30, 2026	14,028,739	-0.2%	3,417,912	4.1
Sep 15, 2026	14,063,517	+8.4%	2,846,711	4.9
Aug 31, 2026	12,973,938	+7.8%	2,308,217	5.6
Aug 14, 2026	12,039,849	-9.3%	2,773,295	4.3
Jul 31, 2026	13,280,607	+3.4%	2,575,575	5.2
Jul 15, 2026	12,845,008	-0.2%	2,018,823	6.4
Jun 30, 2026	12,870,865	+5.5%	3,271,795	3.9
Jun 15, 2026	12,200,158	+2.9%	2,968,539	4.1
May 29, 2026	11,852,360	-3.6%	2,380,675	5.0
May 15, 2026	12,289,634	-5.2%	2,875,509	4.3